Date: November 7, 2024
Time: 8:00 AM (PST), 11:00 AM (EST), 5:00 PM (CET)
Pneumonia is an important infectious disease associated with high morbidity, mortality, and health costs worldwide. Unfortunately, the causative pathogens cannot be identified in approximately 50% of CAP cases due to limitations in traditional microbiological methods. Blood and sputum cultures are affected by poor sample collection, prior antibiotic administration, and delayed processing. Nevertheless, the most frequently identified bacterial pathogens are still Streptococcus pneumoniae and Legionella pneumophila. Urinary antigen tests (UATs) for S. pneumoniae and L. pneumophila have emerged as powerful tools for improving the diagnosis of bacterial respiratory infections, enabling physicians to administer early directed therapy and improve antimicrobial stewardship.
The webinar aiming to present our own experience after the implementation of a new automated solution for Urinary Antigen testing, that overcome some main limitations of the available commercial assays, to help clinicians in improving Pneumonia patients' management.
Learning Objectives
- Provide background information on the main challenges on Pneumonia diagnosis
- Discuss the unmet needs of the current standard of care
- Introduce our new diagnostic approach and how the diagnosis of Pneumonia could be improved
Webinars will be available for unlimited on-demand viewing after live event.